Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted Next Generation Sequencing.

[1]  R. Scott,et al.  Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities , 2015, Prenatal diagnosis.

[2]  A. Dauber,et al.  Insights from exome sequencing for endocrine disorders , 2015, Nature Reviews Endocrinology.

[3]  Gregory P. Forlenza,et al.  Next generation sequencing in endocrine practice. , 2015, Molecular genetics and metabolism.

[4]  D. Wenkert,et al.  Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. , 2015, Bone.

[5]  J. Sire,et al.  Molecular Evolution of the Tissue-nonspecific Alkaline Phosphatase Allows Prediction and Validation of Missense Mutations Responsible for Hypophosphatasia* , 2014, The Journal of Biological Chemistry.

[6]  D. Sillence,et al.  Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment , 2014, American journal of medical genetics. Part A.

[7]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[8]  F. Jakob,et al.  Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia , 2014, European Journal of Human Genetics.

[9]  A. Bloch-Zupan,et al.  Clinical utility gene card for: Hypophosphatasia – update 2013 , 2013, European Journal of Human Genetics.

[10]  T. Taketani,et al.  Clinical and genetic aspects of hypophosphatasia in Japanese patients , 2013, Archives of Disease in Childhood.

[11]  J. Zmuda,et al.  Rare coding variants in ALPL are associated with low serum alkaline phosphatase and low bone mineral density , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  Raymond Dalgleish,et al.  EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta , 2011, European Journal of Human Genetics.

[13]  D. Wenkert,et al.  Hypophosphatasia: Nonlethal disease despite skeletal presentation in utero (17 new cases and literature review) , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[15]  K. Potočki,et al.  Hypophosphatasia: phenotypic variability and possible Croatian origin of the c.1402g>A mutation of TNSALP gene. , 2009, Collegium antropologicum.

[16]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[17]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[18]  P. de Mazancourt,et al.  Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles , 2009, BMC Medical Genetics.

[19]  E. Mornet.  Hypophosphatasia , 2007, Orphanet journal of rare diseases.

[20]  F. Glorieux,et al.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans , 2007, Human mutation.

[21]  S. Mumm,et al.  Homozygosity for TNSALP mutation 1348c>T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. , 2006, The Journal of pediatrics.

[22]  S. Mehta,et al.  Characterization of missense mutations and large deletions in the ALPL gene by sequencing and quantitative multiplex PCR of short fragments. , 2006, Genetic testing.

[23]  T. Uchihashi,et al.  Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia , 2005, European Journal of Pediatrics.

[24]  A. Ménez,et al.  Structural Evidence for a Functional Role of Human Tissue Nonspecific Alkaline Phosphatase in Bone Mineralization* , 2001, The Journal of Biological Chemistry.

[25]  J. Gibrat,et al.  A molecular approach to dominance in hypophosphatasia , 2001, Human Genetics.

[26]  M. Taussig,et al.  Crystal Structure of Alkaline Phosphatase from Human Placenta at 1.8 Å Resolution , 2001, The Journal of Biological Chemistry.

[27]  J. Simmer,et al.  Characterization of a family with dominant hypophosphatasia. , 2000, European journal of oral sciences.

[28]  E. Mornet.  Hypophosphatasia: The mutations in the tissue‐nonspecific alkaline phosphatase gene , 2000, Human mutation.

[29]  R. Pauli,et al.  Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: bent but not broken. , 1999, American journal of medical genetics.

[30]  C. Moore,et al.  Mild autosomal dominant hypophosphatasia: in utero presentation in two families. , 1999, American journal of medical genetics.

[31]  F. Kaper,et al.  Identification of fifteen novel mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in European patients with severe hypophosphatasia , 1998, European Journal of Human Genetics.

[32]  Sheldon,et al.  A substitution at a non-glycine position in the triple-helical domain of pro alpha 2(I) collagen chains present in an individual with a variant of the Marfan syndrome. , 1990, The Journal of clinical investigation.